Skip to content

Single-center, single-blind, randomized, controlled clinical study on the short-term and long-term efficacy of robot-assisted middle pancreatectomy and distal pancreatectomy for the treatment of benign or low-grade pancreatic neck tumors

Single-center, single-blind, randomized, controlled clinical study on the short-term and long-term efficacy of robot-assisted middle pancreatectomy and distal pancreatectomy for the treatment of benign or low-grade pancreatic neck tumors

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036095
Enrollment
Unknown
Registered
2020-08-21
Start date
2022-09-30
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign or Low-grade malignant pancreatic tumor

Interventions

Sponsors

Shanghai Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Signed and dated informed consent; promise to abide by the research procedures and cooperate in the implementation of the whole process of research; 2. Aged >=18 years; 3. Physical fitness score ECOG 01; 4. Preoperative diagnosis meets the following conditions: 1) The tumor is located in the body of the pancreas, and the distal end can retain normal pancreatic tissue >5cm; 2) Preoperative imaging (CT/MRI/PET-CT/PET-MR) consider non-functional pancreatic neuroendocrine tumors, solid pseudopapillary tumors of the pancreas, intraductal papilloma, mucinous cystadenoma, serous Cystic adenoma, mass pancreatitis, pancreatic pseudocyst; 3) Those who have the conditions to perform RMP after the preoperative discussion by the central surgery team doctors; 5. After surgery and anesthesia assessment, patients are suitable for elective or limited-term surgery.

Exclusion criteria

Exclusion criteria: 1. BMI> 35 kg/m2; 2. Be pregnant; 3. History of major upper abdominal surgery or digestive tract reconstruction; 4. Intraoperative findings or postoperative pathology suggest pancreatic ductal adenocarcinoma or other pancreatic malignancies; 5. Past history of malignant tumors; 6. The common bile duct or gastroduodenal artery was damaged during the operation, and the portal vein was reconstructed due to tumor adhesion during the operation. 7. Postoperative complications caused the patient's death during the perioperative period (within 90 days after the operation).

Design outcomes

Primary

MeasureTime frame
endocrine and excorine function of pancreas;

Countries

China

Contacts

Public ContactYusheng SHI

Shanghai Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine

815212808@qq.com+86 13564647826

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026